Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
BörsenkürzelRMTI
Name des UnternehmensRockwell Medical Inc
IPO-datumJan 27, 1998
CEODr. Mark Strobeck, Ph.D.
Anzahl der mitarbeiter244
WertpapierartOrdinary Share
GeschäftsjahresendeJan 27
Addresse30142 Wixom Road
StadtWIXOM
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl48393
Telefon18004493353
Websitehttps://www.rockwellmed.com/
BörsenkürzelRMTI
IPO-datumJan 27, 1998
CEODr. Mark Strobeck, Ph.D.
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten